{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T18:48:28Z","timestamp":1783190908566,"version":"3.54.6"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Yunnan Applied Basic Research Projects-Union Foundation"},{"name":"Yunnan Provincial Department of Science and Technology and Kunming Medical-University","award":["202101AY070001-249"],"award-info":[{"award-number":["202101AY070001-249"]}]},{"name":"Blood disease Clinical medical Center"},{"name":"First People's Hospital of Yunnan Province","award":["2021LCZXXF-XY15"],"award-info":[{"award-number":["2021LCZXXF-XY15"]}]},{"name":"Ten Thousand Person Program"},{"name":"Yunnan Province-The Special Project for Renowned Physicians","award":["YNWR-MY-2019\u2013027"],"award-info":[{"award-number":["YNWR-MY-2019\u2013027"]}]},{"name":"Yunnan Province-The Special Project for Renowned Physicians","award":["KH-SWR-MY-2019\u2013003"],"award-info":[{"award-number":["KH-SWR-MY-2019\u2013003"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To describe the clinical features of Chinese patients with HCQ-induced pigmentation and analyse the potential risk factors associated with HCQ-induced pigmentation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A cross-sectional study was conducted over a duration of 7\u2009months, during which patients who had received HCQ treatment for &amp;gt;6\u2009months were included. Data was collected through a structured questionnaire that encompassed demographic and geographic characteristics, information on HCQ and concomitant medication usage, sun exposure characteristics and hyperpigmentation-related characteristics. Univariate and multivariate analyses were employed to calculate the statistical association between HCQ-induced pigmentation and multiple variables.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Out of 316 patients, 83 (26.3%) patients presented hyperpigmentation during HCQ treatment. Hyperpigmentation was presented after a median duration of HCQ treatment of 12\u2009months (interquartile range, 6.0\u201330.0\u2009months) with a median cumulative dose of 108\u2009g of HCQ (interquartile range, 36\u2013288\u2009g). The most frequently affected sites of pigmentation were the face (60.2%), lower limbs (36.1%) and hands (20.5%). There was a linear decrease in the incidence of pigmentation with increasing daily sun exposure time (P\u2009=\u20090.030). In the multivariate analysis, variables (cumulative HCQ dose and daily sun exposure time) were included in the final models. The results revealed an independent correlation between HCQ-induced pigmentation and daily sun exposure exceeding 1\u2009h (OR: 0.431; 95% CI: 0.208\u20130.892; P\u2009=\u20090.023).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The occurrence of HCQ-induced pigmentation is not uncommon, with an incidence rate of 26.3%. Daily sun exposure time exhibited a protective effect against HCQ-induced pigmentation.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae217","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T21:17:46Z","timestamp":1712611066000},"page":"985-993","source":"Crossref","is-referenced-by-count":4,"title":["Hydroxychloroquine-induced pigmentation in rheumatic diseases: prevalence, clinical features and influencing factors"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9918-0766","authenticated-orcid":false,"given":"Zi-Jing","family":"Yin","sequence":"first","affiliation":[{"name":"Department of Rheumatology, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology , Kunming, Yunnan,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology , Kunming, Yunnan,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology , Kunming, Yunnan,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dachen","family":"Zuo","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology , Kunming, Yunnan,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology , Kunming, Yunnan,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fayou","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology , Kunming, Yunnan,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology , Kunming, Yunnan,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology , Kunming, Yunnan,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqin","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology , Kunming, Yunnan,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuya","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology , Kunming, Yunnan,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology , Kunming, Yunnan,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology , Kunming, Yunnan,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,4,8]]},"reference":[{"key":"2025030500175659700_keae217-B1","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41584-018-0111-8","article-title":"Hydroxychloroquine retinopathy\u2014implications of research advances for rheumatology care","volume":"14","author":"Jorge","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"2025030500175659700_keae217-B2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","article-title":"Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology","volume":"16","author":"Schrezenmeier","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"2025030500175659700_keae217-B3","first-page":"929","article-title":"Subungual pigmentation following prolonged atabrine therapy","volume":"43","author":"Barr","year":"1944","journal-title":"U S Nova Med Bull"},{"key":"2025030500175659700_keae217-B4","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jaad.2020.04.024","article-title":"Characterizing the adverse dermatologic effects of hydroxychloroquine: a systematic review","volume":"83","author":"Sharma","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2025030500175659700_keae217-B5","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/jamadermatol.2013.709","article-title":"Hydroxychloroquine-induced pigmentation in patients with systemic lupus erythematosus","volume":"149","author":"Jallouli","year":"2013","journal-title":"JAMA Dermatol"},{"key":"2025030500175659700_keae217-B6","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1177\/0961203317700486","article-title":"Hydroxychloroquine-induced hyperpigmentation in systemic diseases: prevalence, clinical features and risk factors: a cross-sectional study of 41 cases","volume":"26","author":"Bahloul","year":"2017","journal-title":"Lupus"},{"key":"2025030500175659700_keae217-B7","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1365-2230.2004.01412.x","article-title":"Cutaneous hyperpigmentation during therapy with hydroxychloroquine","volume":"29","author":"Millard","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"2025030500175659700_keae217-B8","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1529-8019.2007.00131.x","article-title":"New concepts in antimalarial use and mode of action in dermatology","volume":"20","author":"Kalia","year":"2007","journal-title":"Dermatol Ther"},{"key":"2025030500175659700_keae217-B9","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/03009740701769735","article-title":"Hyperpigmentation of the skin due to hydroxychloroquine","volume":"37","author":"Rood","year":"2008","journal-title":"Scand J Rheumatol"},{"key":"2025030500175659700_keae217-B10"},{"key":"2025030500175659700_keae217-B11","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1751-7176.2008.07572.x","article-title":"Predictive validity of a medication adherence measure in an outpatient setting","volume":"10","author":"Morisky","year":"2008","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2025030500175659700_keae217-B12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/15569527.2010.521225","article-title":"Antimalarial cutaneous side effects: a study in 209 users","volume":"30","author":"Skare","year":"2011","journal-title":"Cutan Ocul Toxicol"},{"key":"2025030500175659700_keae217-B13","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.55563\/clinexprheumatol\/styx9u","article-title":"The safety profile of hydroxychloroquine: major cutaneous and extracutaneous adverse events","volume":"39","author":"Gisondi","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"2025030500175659700_keae217-B14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1468-3083.2006.01494.x","article-title":"Hydroxychloroquine-induced pigmentation in two patients with systemic lupus erythematosus","volume":"20","author":"Reynaert","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025030500175659700_keae217-B15","doi-asserted-by":"crossref","first-page":"E212","DOI":"10.1503\/cmaj.150622","article-title":"Hydroxychloroquine-related skin discoloration","volume":"189","author":"Coulombe","year":"2017","journal-title":"CMAJ"},{"key":"2025030500175659700_keae217-B16","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1177\/1358863X16650276","article-title":"Serpentine supravenous hyperpigmentation due to hydroxychloroquine","volume":"21","author":"Lau","year":"2016","journal-title":"Vasc Med"},{"key":"2025030500175659700_keae217-B17","first-page":"921","article-title":"Isolated hyperpigmentation of the oral mucosa due to hydroxychloroquine","volume":"10","author":"Kalampalikis","year":"2012","journal-title":"J Dtsch Dermatol Ges"},{"key":"2025030500175659700_keae217-B18","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.1600-0560.2008.01004.x","article-title":"Hydroxychloroquine-induced hyperpigmentation: the staining pattern","volume":"35","author":"Puri","year":"2008","journal-title":"J Cutan Pathol"},{"key":"2025030500175659700_keae217-B19","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","article-title":"2019 update of the EULAR recommendations for the management of systemic lupus erythematosus","volume":"78","author":"Fanouriakis","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2025030500175659700_keae217-B20","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1001\/jamaophthalmol.2014.3459","article-title":"The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy","volume":"132","author":"Melles","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"2025030500175659700_keae217-B21","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4269\/ajtmh.1945.s1-25.469","article-title":"Pigmentation of the palate and subungual tissues associated with suppressive quinacrine hydrochloride therapy","volume":"25","author":"Lippard","year":"1945","journal-title":"Am J Trop Med Hyg"},{"key":"2025030500175659700_keae217-B22","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tripleo.2008.07.022","article-title":"Pigmentation of the hard palate","volume":"107","author":"Lerman","year":"2009","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol"},{"key":"2025030500175659700_keae217-B23","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1600-0714.1986.tb00660.x","article-title":"Pigmentary changes in rat oral mucosa following antimalarial therapy","volume":"15","author":"Savage","year":"1986","journal-title":"J Oral Pathol"},{"key":"2025030500175659700_keae217-B24","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1067\/moe.2000.106340","article-title":"Oral mucosal hyperpigmentation secondary to antimalarial drug therapy","volume":"90","author":"Kleinegger","year":"2000","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"2025030500175659700_keae217-B25","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2340\/00015555-0889","article-title":"Hyperpigmented forearms and nail: a quiz","volume":"90","author":"Patsatsi","year":"2010","journal-title":"Acta Dermato Venereol"},{"key":"2025030500175659700_keae217-B26","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/exd.13332","article-title":"UV adaptation: pigmentation and protection against overexposure","volume":"26","author":"de Gruijl","year":"2017","journal-title":"Exp Dermatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae217\/57237862\/keae217.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/3\/985\/57237862\/keae217.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/3\/985\/57237862\/keae217.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:18:55Z","timestamp":1741133935000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/3\/985\/7642412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,8]]},"references-count":26,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,4,8]]},"published-print":{"date-parts":[[2025,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae217","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2024,4,8]]}}}